The Peripheral Cannabinoid Receptor, Cb2, in Retrovirally-Induced Leukemic Transformation and Normal Hematopoiesis

References

• Nichols J., Niraer S. D. Transcription factors, translocations, and leukemia. Blood 1992; 80: 2953–2963
   PubMed Web of Science ®Google Scholar
• Look T. A. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059–1064
   PubMed Web of Science ®Google Scholar
• Ferreira O. C., Jr, Planelles V., Rosenblatt J. D. Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Reviews 1997; 11: 91–104
   PubMed Web of Science ®Google Scholar
• Bos J. L. ras oncogenes in human cancer: a review. Cancer Research 1989; 49: 4682–4689
   PubMed Web of Science ®Google Scholar
• Jonkers J., Berns A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochimica Biophysica Acta 1996; 1287: 29–57
   PubMed Web of Science ®Google Scholar
• Wolff L. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. Biochimica Biophysica Acta 1997; 1332: F67–104
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Kinzler K. W. The multistep nature of cancer. Trends in Genetics 1993; 9: 138–141
   PubMed Web of Science ®Google Scholar
• Valk P. J.M., Joosten M., Vankan Y., Lowenberg B., Delwel R. A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites. Nucleic Acids Research 1997; 25: 4419–4421
   PubMed Web of Science ®Google Scholar
• Sorensen A. B., Duch M., Amtoft H. W., Jorgensen P., Pedersen F. S. Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3–3. Journal of Virology 1996; 70: 4063–4070
   PubMed Web of Science ®Google Scholar
• Sorensen A. B., Duch M, Jorgensen P., Pedersen F. S. Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. Journal of Virology 1993; 67: 7118–7124
   PubMed Web of Science ®Google Scholar
• Silver J., Keerikatte V. Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. Journal of Virology 1989; 63: 1924–1928
   PubMed Web of Science ®Google Scholar
• Loh E. Y., Elliott J. F., Cwirla S., Lanier L. L., Davis M. M. Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science 1989; 243: 217–220
   PubMed Web of Science ®Google Scholar
• Minami M., Poussin K., Brechot C., Paterlini P. A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. Genomics 1995; 29: 403–408
   PubMed Web of Science ®Google Scholar
• Mucenski M. L., Taylor B. A., Ihle J. N., Hartley J. W., Morse H. C., III, Jenkins N. A., Copeland N. G. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Molecular and Cellular Biology 1988; 8: 301–308
   PubMed Web of Science ®Google Scholar
• Morishita K., Parker D. S., Mucenski M. L., Jenkins N. A., Copeland N. G., Ihle J. N. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-depen-dent myeloid leukemia cell lines. Cell 1988; 54: 831–840
   PubMed Web of Science ®Google Scholar
• Nakamura T., Largaespada D. A., Shaughnessy J. D., Jr., Jenkins N. A., Copeland N. G. Cooperative activation of Hoxa and Pbxl-related genes in murine myeloid leukaemias. Nature Genetics 1996; 12: 149–153
   PubMed Web of Science ®Google Scholar
• Borrow J., Shearman A. M., Stanton V. P., Jr., Becher R., Collins T., Williams A. J., Dube I., Katz R, Kwong Y. L., Morris C., et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nature Genetics 1996; 12: 159–167
   PubMed Web of Science ®Google Scholar
• Nakamura T., Largaespada D. A., Lee M. P., Johnson L. A., Ohyashiki K., Toyama K., Chen S. J., Willman C. L., Chen I. M., Feinberg A. P., et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nature Genetics 1996; 12: 154–158
   PubMed Web of Science ®Google Scholar
• Ben-David Y, Giddens E. B., Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proceedings of the National Academy of Sciences of the USA 1990; 87: 1332–1336
   PubMed Web of Science ®Google Scholar
• Bergeron D., Poliquin L., Kozak C. A., Rassart E. Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas. Journal of Virology 1991; 65: 7–15
   PubMed Web of Science ®Google Scholar
• Bergeron D., Houde J., Poliquin L., Barbeau B., Rassart E. Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias. Leukemia 1993; 7: 954–962
   PubMed Web of Science ®Google Scholar
• Moskow J. J., Bullrich F., Huebner K., Daar I. O, Buchberg A. M. Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Molecular and Cellular Biology 1995; 15: 5434–5443
   PubMed Web of Science ®Google Scholar
• Buchberg A. M., Bedigian H. G., Jenkins N. A., Copeland N. G. Evi-2, a common integration site involved in murine myeloid leukemogenesis. Molecular and Cellular Biology 1990; 10: 4658–4666
   PubMed Web of Science ®Google Scholar
• Ru M., Shustik C., Rassart E. Graffi murine leukemia virus: molecular cloning and characterization of the -myeloid leukemia-inducing agent. Journal of Virology 1993; 67: 4722–4731
   PubMed Web of Science ®Google Scholar
• Langdon W. Y., Hoffman P. M., Silver J. E., Buckler C. E., Hartley J. W., Ruscetti S. K., Morse H. C., III. Identification of a spleen focus-forming virus in erythroleukemic mice infected with a wild-mouse ecotropic murine leukemia virus. Journal of Virology 1983; 46: 230–238
   PubMed Web of Science ®Google Scholar
• Holmes K. L., Palaszynski E., Fredrickson T. N., Morse H. C., III, Ihle J. N. Correlation of cell-surface pheno-type with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proceedings of the National Academy of Sciences of the USA 1985; 82: 6687–6691
   PubMed Web of Science ®Google Scholar
• Valk P. J., Hoi S., Vankan Y, Ihle J. N., Askew D., Jenkins N. A., Gilbert D. J., Copeland N. G., De Both N. J., Lowenberg B., et al. The genes encoding the peripheral can-nabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evill. Journal of Virology 1997; 71: 6796–6804
   PubMed Web of Science ®Google Scholar
• Pertwee R. G. Pharmalogical, physiological and clinical implications of the discovery of cannabinoid receptors: an overview. Cannabinoid receptors, R. Pertwee. Academic Press, London 1995; 1–34
   Google Scholar
• Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61–65
   PubMed Web of Science ®Google Scholar
• Shire D., Calandra B., Rinaldi-Carmona M., Oustric D., Pessegue B., Bonnin-Cabanne O., Le Fur G., Caput D., Ferrara P. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochimica Biophysica Acta 1996; 1307: 132–136
   PubMed Web of Science ®Google Scholar
• Shire D., Carillon C, Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. Journal of Biological Chemistry 1995; 270: 3726–3731
   PubMed Web of Science ®Google Scholar
• Kozak M. Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes. Molecular and Cellular Biology 1987; 7: 3438–3445
   PubMed Web of Science ®Google Scholar
• Curnow K. M., Pascoe L., White P. C. Genetic-analysis of the human type-1 angiotensin II receptor. Molecular Endocrinology 1992; 6: 1113–1118
   PubMed Web of Science ®Google Scholar
• Marth J. D., Overell R. W., Meier K. E., Krebs E. G., Perlmutter R. M. Translational activation of the Ick proto-oncogene. Nature 1988; 332: 171–173
   PubMed Web of Science ®Google Scholar
• Ratner L., Thielan B., Collins T. Sequences of the 5′ portion of the human c-sis gene: characterization of the transcriptional promoter and regulation of expression of the protein product by 5′ untranslated mRNA sequences. Nucleic Acids Research 1987; 15: 6017–6036
   PubMed Web of Science ®Google Scholar
• Matsuda L. A., Bonner T. I. Molecular biology of the cannabinoid receptor. Cannabinoid receptors, R. Pertwee. Academic Press, London 1995; 117–140
   Google Scholar
• Young D., Waitches G., Birchmeier C., Fasano O., Wigler M. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 1986; 45: 711–719
   PubMed Web of Science ®Google Scholar
• Janssen J. W., Steenvoorden A. C., Schmidtberger M., Bartram C. R. Activation of the mas oncogene during transfection of monoblastic cell line DNA. Leukemia 1988; 2: 318–320
   PubMed Web of Science ®Google Scholar
• Schweifer N., Valk P. J., Delwel R., Cox R., Francis F., Meier-Ewert S., Lehrach H., Barlow D. P. Characterization of the C3 YAC contig from proximal mouse chromosome 17 and analysis of allelic expression of genes flanking the imprinted Igf2r gene. Genomics 1997; 43: 285–297
   PubMed Web of Science ®Google Scholar
• Fowler M. L., Nakai H., Byers M. G., Fukushima H., Eddy R. L., Henry W. M., Haley L. L., Js O. B., Shows T. B. Chromosome 1 localization of the human alpha-L-fucosidase structural gene with a homologous site on chromosome 2. Cytogenetics and Cell Genetics 1986; 43: 103–108
   PubMedGoogle Scholar
• Bloomfield C D., Garson O. M., Volin L., Knuutila S., De La Chapelle A. t(1;3)(p36;q21) in acute nonlym-phocytic leukemia: a new cytogenetic-clinicopathologic association. Blood 1985; 66: 1409–1413
   PubMed Web of Science ®Google Scholar
• Viguie F., Marie I. P., Poler F., Bernadou A. Three cases of preleukemic myelodysplastic disorders with the same translocation t(1;3). Cancer Genetics Cytogenetics 1986; 19: 213–218
   PubMed Web of Science ®Google Scholar
• Fundia A., Gorla N., Larripa I. Spontaneous chromosome aberrations in Fanconi's anemia patients are located at fragile sites and acute myeloid leukemia breakpoints. Hereditas 1994; 120: 47–50
   PubMed Web of Science ®Google Scholar
• Whang-Peng J., Knutsen T., Jaffe E. S., Steinberg S. M., Raffeld M., Zhao W. P., Duffey P., Condron K., Yano T., Longo D. L. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood 1995; 85: 203–216
   PubMed Web of Science ®Google Scholar
• Johansson B., Waldenstrom J., Hasselblom S., Mitelman F. Waldenstrom's macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21). Leukemia 1995; 9: 1136–1138
   PubMed Web of Science ®Google Scholar
• Thangavelu M., Finn W. G., Yelavarthi K. K., Roenigk H. H., Jr., Samuelson E., Peterson L., Kuzel T. M., Rosen S. T. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome. Blood 1997; 89: 3371–3377
   PubMed Web of Science ®Google Scholar
• Thompson F. H., Emerson J., Olson S., Weinstein R., Leavitt S. A., Leong S. P., Emerson S., Trent J. M., Nelson M. A., Salmon S. E., et al. Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genetics Cytogenetics 1995; 83: 93–104
   PubMed Web of Science ®Google Scholar
• Thompson F. H., Taetle R., Trent J. M., Liu Y, Massey-Brown K., Scott K. M., Weinstein R. S., Emerson J. C., Alberts D. S., Nelson M. A. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma. Cancer Genetics Cytogenetics 1997; 96: 106–110
   PubMed Web of Science ®Google Scholar
• Cheng N. C., Van Roy N., Chan A., Beitsma M., Westerveld A., Speleman F., Versteeg R. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35–36 region, only one of which is associated with N-myc amplification. Oncogene 1995; 10: 291–297
   PubMed Web of Science ®Google Scholar
• Biegel J. A., White P. S., Marshall H. N., Fujimori M., Zackai E. H., Scher C. D., Brodeur G. M., Emanuel B. S. Constitutional 1p36 deletion in a child with neuroblastoma. American Journal of Human Genetics 1993; 52: 176–182
   PubMed Web of Science ®Google Scholar
• Carchman R. A., Harris L. S., Munson A. E. The inhibition of DNA synthesis by cannabinoids. Cancer Research 1976; 36: 95–100
   PubMed Web of Science ®Google Scholar
• Murison G., Chubb C. B., Maeda S., Gemmell M. A., Huberman E. Cannabinoids induce incomplete maturation of cultured human leukemia cells. Proceedings of the National Academy Sciences of the USA 1987; 84: 5414–5418
   PubMed Web of Science ®Google Scholar
• Rowley J. T., Rowley P. T. Tetrahydrocannabinol inhibits adenyl cyclase in human leukemia cells. Life Sciences 1990; 46: 217–222
   PubMed Web of Science ®Google Scholar
• Schwarz H., Blanco F. J., Lotz M. Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. Journal of Neuroimmunology 1994; 55: 107–115
   PubMed Web of Science ®Google Scholar
• Kaminski N. E., Abood M. E., Kessler F. K., Martin B. R., Schatz A. R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Molecular Pharmacology 1992; 42: 736–742
   PubMed Web of Science ®Google Scholar
• Lynn A. B., Herkenham M. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. Journal of Pharmacology and Experimental Therapeutics 1994; 268: 1612–1623
   PubMed Web of Science ®Google Scholar
• Bouaboula M., Rinaldi M., Carayon P., Carillon C., Delpech B., Shire D., Le Fur G., Casellas P. Cannabinoid-receptor expression in human leukocytes. European Journal of Biochemistry 1993; 214: 173–180
   PubMedGoogle Scholar
• Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564
   PubMed Web of Science ®Google Scholar
• Gerard C M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochemical Journal 1991; 279: 129–134
   PubMed Web of Science ®Google Scholar
• Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. European Journal of Biochemistry 1995; 232: 54–61
   PubMedGoogle Scholar
• Pettit D. A., Anders D. L., Harrison M. P., Cabral G. A. Cannabinoid receptor expression in immune cells. Advances in Experimental Medicin and Biology 1996; 402: 119–129
   PubMedGoogle Scholar
• Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S. D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proceedings of the National Academy of Sciences of the USA 1995; 92: 3376–3380
   PubMed Web of Science ®Google Scholar
• Valk P., Verbakel S., Vankan Y., Hoi S., Mancham S., Ploemacher R., Mayen A., Lowenberg B., Delwel R. Anandamide, a natural ligand for the peripheral can nabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 1997; 90: 1448–1457
   PubMed Web of Science ®Google Scholar
• Derocq J. M., Segui M., Marchand J., Le Fur G., Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Letters 1995; 369: 177–182
   PubMed Web of Science ®Google Scholar
• Felder C. C., Veluz J. S., Williams H. L., Briley E. M., Matsuda L. A. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Molecular Pharmacology 1992; 42: 838–845
   PubMed Web of Science ®Google Scholar
• Bisogno T., Maurelli S., Melck D., De Petrocellis L., Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. Journal of Biological Chemistry 1997; 272: 3315–3323
   PubMed Web of Science ®Google Scholar
• Slipetz D. M., Gp O. N., Favreau L., Dufresne C., Gallant M., Gareau Y., Guay D., Labelle M, Metters K. M. Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Molecular Pharmacology 1995; 48: 352–361
   PubMed Web of Science ®Google Scholar
• Bayewitch M., Avidor-Reiss T., Levy R., Barg J., Mechoulam R., Vogel Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Letters 1995; 375: 143–147
   PubMed Web of Science ®Google Scholar
• Felder C. C., Joyce K. E., Briley E. M., Mansouri J., Mackie K., Blond O., Lai Y, Ma A. L., Mitchell R. L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Molecular Pharmacology 1995; 48: 443–450
   PubMed Web of Science ®Google Scholar
• Lee M, Yang K. H., Kaminski N. E. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. Journal of Pharmacology and Experimental Therapeutics 1995; 275: 529–536
   PubMed Web of Science ®Google Scholar
• Bayewitch M., Rhee M. H., Avidor-Reiss T., Breuer A., Mechoulam R., Vogel Z. (-)-Delta9-tetrahydro-cannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. Journal of Biological Chemistry 1996; 271: 9902–9905
   PubMed Web of Science ®Google Scholar
• Bouaboula M., Poinot-Chazel C, Marchand J., Canat X., Bourrie B., Rinaldi-Carmona M., Calandra B., Le Fur G., Casellas P. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. European Journal of Biochemistry 1996; 237: 704–711
   PubMedGoogle Scholar
• Post G. R., Brown J. H. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB Journal 1996; 10: 741–749
   PubMed Web of Science ®Google Scholar
• Seger R., Krebs E. G. The MAPK signaling cascade. FASEB Journal 1995; 9: 726–735
   PubMed Web of Science ®Google Scholar
• Crespo P., Xu N., Simonds W. F., Gutkind J. S. Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 1994; 369: 418–420
   PubMed Web of Science ®Google Scholar
• Derkinderen P., Toutant M., Burgaya R, Le Bert M., Siciliano J. C., De Franciscis V., Gelman M., Girault J. A. Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 1996; 273: 1719–1722
   PubMed Web of Science ®Google Scholar
• Dikic I., Tokiwa G., Lev S., Courtneidge S. A., Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 1996; 383: 547–550
   PubMedGoogle Scholar
• Marrero M. B., Schieffer B., Paxton W. G., Heerdt L., Berk B. C., Delafontaine P., Bernstein K. E. Direct stimulation of Jak/STAT pathway by the angiotensin II ATI receptor. Nature 1995; 375: 247–250
   PubMed Web of Science ®Google Scholar
• Allen L. R, Lefkowitz R. J., Caron M. G., Cotecchia S. G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proceedings of the National Academy of Sciences of the U S A 1991; 88: 11354–11358
   PubMed Web of Science ®Google Scholar
• J Suarez H. G., Russo D., Wicker R., Du Villard J. A., Filetti S., Caillou B., Schlumberger M. Role of somatic genetic alterations of the cAMP pathway in thyroid hyperfunctioning tumorigenesis. Journal of Cellular Biochemistry Supplement 1995; 19A: 44
   Google Scholar
• Whitehead I., Kirk H., Kay R. Expression cloning of oncogenes by retroviral transfer of cDNA libraries. Molecular and Cellular Biology 1995; 15: 704–710
   PubMed Web of Science ®Google Scholar
• Gutkind J. S., Novotny E. A., Brann M. R., Robbins K. C. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proceedings of the National Academy of Sciences of the USA 1991; 88: 4703–4707
   PubMed Web of Science ®Google Scholar
• Julius D., Livelli T. J., Jessell T. M., Axel R. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 1989; 244: 1057–1062
   PubMed Web of Science ®Google Scholar
• Van 'T Veer L. J., Van Den Berg-Bakker L. A., Hermens R. P., Deprez R. L., Schrier P. I. High frequency of mas oncogene activation detected in the NIH3T3 tumorigenicity assay. Oncogene Research 1988; 3: 247–254
   PubMedGoogle Scholar
• Bergeron D., Poliquin L., Houde J., Barbeau B., Rassart E. Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-E MuLV-induced non-T-, non-B-cell leukemias. Virology 1992; 191: 661–669
   PubMed Web of Science ®Google Scholar
• Blatt C, Aberdam D., Schwartz R., Sachs L. DNA rearrangement of a homeobox gene in myeloid leukaemic cells. Embo Journal 1988; 7: 4283–4290
   PubMed Web of Science ®Google Scholar
• Ben-David Y., Giddens E. B., Letwin K., Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes and Development 1991; 5: 908–918
   PubMed Web of Science ®Google Scholar
• Gisselbrecht S., Fichelson S., Sola B., Bordereaux D., Hampe A., Andre C, Galibert F., Tambourin P. Frequent c-fms activation by proviral insertion in mouse myeloblasts leukaemias. Nature 1987; 329: 259–261
   PubMed Web of Science ®Google Scholar
• Mayo M. W., Wang X. Y., Algate P. A., Arana G. F., Hoyle P. E., Steelman L. S., McCubrey J. A. Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleukin-3-depen-dent hematopoietic cells. Blood 1995; 86: 3139–3150
   PubMed Web of Science ®Google Scholar
• Algate P. A., McCubrey J. A. Autocrine transformation of hemopoietic cells resulting from cytokine message stabilization after intracisternal A particle transposition. Oncogene 1993; 8: 1221–1232
   PubMed Web of Science ®Google Scholar
• Shen-Ong G. L., Morse H. C., III, Potter M., Mushinski J. F. Two modes of c-myb activation in virus-induced mouse myeloid tumors. Molecular and Cellular Biology 1986; 6: 380–392
   PubMed Web of Science ®Google Scholar
• Askew D. S., Bartholomew C., Buchberg A. M., Valentine M. B., Jenkins N. A., Copeland N. G., Ihle J. N. His-1 and His-2: identification and chromosomal mapping of two commonly rearranged sites of viral integration in a myeloid leukemia. Oncogene 1991; 6: 2041–2047
   PubMed Web of Science ®Google Scholar
• Roller R., Krall M., Mock B., Bies J., Nazarov V., Wolff L. Mmll, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10. Virology 1996; 224: 224–234
   PubMed Web of Science ®Google Scholar
• Dobner T., Wolf I., Emrich T., Lipp M. Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma. European Journal of Immunology 1992; 22: 2795–2799
   PubMed Web of Science ®Google Scholar
• Ross P. C., Figler R. A., Corjay M. H., Barber C. M., Adam N., Harcus D. R., Lynch K. R. RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution. Proceedings of the National Academy of Sciences of the U S A 1990; 87: 3052–3056
   PubMed Web of Science ®Google Scholar
• Nystedt S., Larsson A. K., Aberg H., Sundelin J. The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. Journal of Biological Chemistry 1995; 270: 5950–5955
   PubMed Web of Science ®Google Scholar
• Sprenger H., Lloyd A. R., Lautens L. L., Bonner T. I., Kelvin D. J. Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. Journal of Biological Chemistry 1994; 269: 11065–11072
   PubMed Web of Science ®Google Scholar
• Sprenger H., Lloyd A. R., Kelvin D. J. Promoter analysis of the human interleukin-8 receptor genes, IL-8RA and IL-8RB. Immunobiology 1995; 193: 334–340
   PubMed Web of Science ®Google Scholar
• Gerard N. P., Bao L., Xiao-Ping H., Eddy R. L., Jr., Shows T. B., Gerard C. Human chemotaxis receptor genes cluster at 19q13.3–13.4. Characterization of the human C5a receptor gene. Biochemistry 1993; 32: 1243–1250
   PubMed Web of Science ®Google Scholar
• Barella L., Loetscher M., Tobler A., Baggiolini M., Moser B. Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. Biochemical Journal 1995; 309: 773–779
   PubMed Web of Science ®Google Scholar
• Gao J. L., Kuhns D. B., Tiffany H. L., McDermott D., Li X., Francke U., Murphy P. M. Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor. Journal of Experimental Medicin 1993; 177: 1421–1427
   PubMed Web of Science ®Google Scholar
• Ammar D. A., Eadie D. M., Wong D. J., Ma Y. Y., Kolakowski L. F., Jr, Yang-Feng T. L., Thompson D. A. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics 1996; 38: 392–398
   PubMed Web of Science ®Google Scholar
• Marchese A., Heiber M., Nguyen T., Heng H. H., Saldivia V. R., Cheng R., Murphy P. M., Tsui L. C., Shi X., Gregor P., et al. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y., and somatostatin receptors. Genomics 1995; 29: 335–344
   PubMed Web of Science ®Google Scholar
• Howard A. D., Tan C, Shiao L. L., Palyha O. C., McKee K. K., Weinberg D. H., Feighner S. D., Cascieri M. A., Smith R. G., Van Der Ploeg L. H., et al. Molecular cloning and characterization of a new receptor for galanin. FEBS Letters 1997; 405: 285–290
   PubMed Web of Science ®Google Scholar
• Bachvarov D. R., Saint-Jacques E., Larrivee J. F., Levesque L., Rioux F, Drapeau G., Marceau F. Cloning and pharmacological characterization of the rabbit bradykinin B2 receptor. Journal of Pharmacology and Experimental Therapeutics 1995; 275: 1623–1630
   PubMed Web of Science ®Google Scholar
• Bachvarov D. R., Hess J. F., Menke J. G., Larrivee J. F., Marceau F. Structure and genomic organization of the human B1 receptor gene for kinins (BDKRB1). Genomics 1996; 33: 374–381
   PubMed Web of Science ®Google Scholar
• Garrett J. E., Capuano I. V., Hammerland L. G., Hung B. C., Brown E. M., Hebert S. C., Nemeth E. F, Fuller F. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. Journal of Bio logical Chemistry 1995; 270: 12919–12925
   PubMed Web of Science ®Google Scholar
• Roca A. L., Godson C, Weaver D. R., Reppert S. M. Structure, characterization, and expression of the gene encoding the mouse Mella melatonin receptor. Endocrinology 1996; 137: 3469–3477
   PubMed Web of Science ®Google Scholar